ArticleRheumatology and immunology research2025

Rituximab in the treatment of anti-HMGCR immune-mediated necrotizing myopathy: Two cases successfully treated.

Giulia Micheli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.